An update from Petros Pharmaceuticals ( (PTPI) ) is now available.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Petros Pharmaceuticals has amended its employment agreement with President Fady Boctor, allowing him to engage in other consulting roles, provided no conflicts arise. The amendment also adjusts his salary to $280,000 annually and sets the employment term to end on December 31, 2024. This move could signal strategic adjustments within the company’s leadership structure.
Find detailed analytics on PTPI stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue